University of Pennsylvania (Penn Med) is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
University of Pennsylvania (Penn Med) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion.
Sponsors: Bayer.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Pennsylvania (Penn Med) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Pennsylvania (Penn Med) has 1 clinical trials on record, with 1 currently active. Their work covers Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion.
University of Pennsylvania (Penn Med) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.